Austin, TXNCT06724640Now EnrollingIRB Ready

HIV Infections Clinical Trial in Austin, TX

Access cutting-edge hiv infections treatment through this clinical trial at a research site in Austin. Study-provided care at no cost to qualified participants.

Sponsored by ViiV Healthcare

Quick Self-Assessment

See if you qualify for this Austin location

Preparing your pre-screening questions…

Expert Care in Austin

Access hiv infections specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hiv infections treatment provided free

Apply for This Austin Location

Check if you qualify for this hiv infections clinical trial in Austin, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Austin

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Austin site if eligible
  4. 4Begin participation

About This HIV Infections Study in Austin

The purpose of this study is to investigate safety, pharmacokinetics and tolerability following single ascending dose (SAD) and multiple ascending doses (MAD) of VH4011499 administered subcutaneously (SC) and intramuscularly (IM) in participants without HIV.

Sponsor: ViiV Healthcare

Who Can Participate

Inclusion Criteria

Participant must be 18 to 55 years of age inclusive, at the time of signing the informed consent.
Participants who are overtly healthy.
Participants may be male or female. Participants assigned female at birth are eligible to participate if they are not pregnant, not planning to become pregnant during the study, not breast/chest feeding or planning to breast/chest feed during the study and one of the following applies:
Is a Participant of Nonchildbearing potential (PONCBP)
Is a Participant of Childbearing potential (POCBP) and using a highly effective method of contraception through 78 weeks after the last dose of parenteral VH4011499 or through the end of the study. The investigator is responsible for review of medical history, menstrual history and recent sexual activity to decrease the risk for inclusion of a POCBP with an early pregnancy.
Capable of giving signed informed consent.

Exclusion Criteria

History or presence of cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological, neurological or psychiatric disorders capable of significantly altering the absorption, metabolism, or elimination of drugs; constituting a risk when taking the study intervention or interfering with the interpretation of data.
Abnormal blood pressure.
Lymphoma, leukemia, or any malignancy within the past 5 years except for basal cell or squamous epithelial carcinomas of the skin that have been resected with no evidence of metastatic disease for 3 years.
Breast cancer within the past 10 years.
Current or chronic history of liver disease, or known hepatic or biliary abnormalities.
History of clinically relevant hepatitis within last 6 months.
Patients with chronic hepatitis B infection.
History of sensitivity to any of the study interventions, a history of drug allergy or other allergy that contraindicates their participation.
The participant has an underlying skin disease or disorder that would interfere with assessment of injection sites.
Participants considered to have insufficient musculature to allow safe VH4011499 intramuscular administration will be excluded.
History of or on-going high-risk behaviors that may put the participant at increased risk for HIV acquisition.
Any preexisting physical or mental condition which may interfere with the participant's ability to comply with the dosing schedule and/or protocol evaluations or which may compromise the safety of the participant.
Past or intended use over-the-counter or prescription medication (including herbal medications) within 7 days prior to dosing
Exposure to more than 4 new investigational products within 12 months prior to the first dosing day.
Current enrollment or recent past participation in another investigational study.
Positive HIV antibody/antigen test.
ALT more than or equal to (\>=)1.5x upper limit of normal (ULN), Total bilirubin \>=1.5x ULN (isolated total bilirubin more than (\>)1.5xULN), and/or estimated creatinine clearance (eGFR) of less than (\<)60 millilitre per minute (mL/min)/1.73 square meter (m\^2).
Regular use of tobacco or nicotine-containing products, regular alcohol consumption and/or use of known drugs of abuse.
QT interval corrected for heart rate according to Fridericia's formula (QTcF) \>450 msec.
Evidence of previous myocardial infarction, any conduction abnormality, any significant arrhythmia, non-sustained or sustained ventricular tachycardia, and/or sinus pauses (\>3 seconds).
The participant has a tattoo or other dermatological condition overlying the location of injection or a prior history of silicone implants or fillers which may interfere with interpretation of ISRs or administration of study product.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Austin?

Yes, this clinical trial (NCT06724640) has an active research site in Austin, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HIV Infections Treatment Options in Austin, TX

If you're searching for hiv infections treatment options in Austin, TX, this clinical trial (NCT06724640) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Austin research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv infections specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hiv infections clinical trials near you to find additional studies recruiting in your area.

More HIV AIDS Trials in Austin, TX

See all hiv aids clinical trials recruiting in Austin — not just this study.

Browse HIV AIDS Trials in Austin →

Browse More Trials by Condition

HIV AIDS TrialsAll Conditions →

Ready to Join in Austin?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Austin, TX